171 related articles for article (PubMed ID: 24799886)
1. Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.
Punapart M; Eltermaa M; Oflijan J; Sütt S; Must A; Kõks S; Schalkwyk LC; Fernandes C; Vasar E; Soomets U; Terasmaa A
PPAR Res; 2014; 2014():349525. PubMed ID: 24799886
[TBL] [Abstract][Full Text] [Related]
2. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
[TBL] [Abstract][Full Text] [Related]
3. Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.
Terasmaa A; Soomets U; Oflijan J; Punapart M; Hansen M; Matto V; Ehrlich K; Must A; Kõks S; Vasar E
J Physiol Biochem; 2011 Sep; 67(3):381-90. PubMed ID: 21461749
[TBL] [Abstract][Full Text] [Related]
4. The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor
Ma Y; Wang M; Guo S; Li T; Liu X; Zhao L
Front Pharmacol; 2022; 13():1048728. PubMed ID: 36425583
[TBL] [Abstract][Full Text] [Related]
5. Effect of 4-phenylbutyrate and valproate on dominant mutations of WFS1 gene in Wolfram syndrome.
Batjargal K; Tajima T; Jimbo EF; Yamagata T
J Endocrinol Invest; 2020 Sep; 43(9):1317-1325. PubMed ID: 32219690
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma.
Kimura A; Guo X; Noro T; Harada C; Tanaka K; Namekata K; Harada T
Neurosci Lett; 2015 Feb; 588():108-13. PubMed ID: 25555796
[TBL] [Abstract][Full Text] [Related]
7. Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.
Mitton KP; Guzman AE; Deshpande M; Byrd D; DeLooff C; Mkoyan K; Zlojutro P; Wallace A; Metcalf B; Laux K; Sotzen J; Tran T
Mol Vis; 2014; 20():1527-44. PubMed ID: 25489226
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects.
Jergil M; Kultima K; Gustafson AL; Dencker L; Stigson M
Toxicol Sci; 2009 Mar; 108(1):132-48. PubMed ID: 19136453
[TBL] [Abstract][Full Text] [Related]
9. Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway.
Kõks S; Soomets U; Paya-Cano JL; Fernandes C; Luuk H; Plaas M; Terasmaa A; Tillmann V; Noormets K; Vasar E; Schalkwyk LC
Physiol Genomics; 2009 May; 37(3):249-59. PubMed ID: 19293327
[TBL] [Abstract][Full Text] [Related]
10. Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver.
Zhang L; Chu X; Wang H; Xie H; Guo C; Cao L; Zhou X; Wang G; Hao H
Eur J Pharmacol; 2013 Dec; 721(1-3):277-85. PubMed ID: 24056123
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic gene expression profile indicates a reduction in G protein signaling in the Wfs1 mutant mice.
Kõks S; Soomets U; Plaas M; Terasmaa A; Noormets K; Tillmann V; Vasar E; Fernandes C; Schalkwyk LC
Physiol Genomics; 2011 Dec; 43(24):1351-8. PubMed ID: 22028430
[TBL] [Abstract][Full Text] [Related]
12. Prohormone convertase 2 activity is increased in the hippocampus of Wfs1 knockout mice.
Tein K; Kasvandik S; Kõks S; Vasar E; Terasmaa A
Front Mol Neurosci; 2015; 8():45. PubMed ID: 26379490
[TBL] [Abstract][Full Text] [Related]
13. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.
Lampen A; Grimaldi PA; Nau H
Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700
[TBL] [Abstract][Full Text] [Related]
14. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
[TBL] [Abstract][Full Text] [Related]
15. Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction.
van Breda SGJ; Claessen SMH; van Herwijnen M; Theunissen DHJ; Jennen DGJ; de Kok TMCM; Kleinjans JCS
Toxicology; 2018 Jan; 393():160-170. PubMed ID: 29154799
[TBL] [Abstract][Full Text] [Related]
16. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice.
Avery LB; Bumpus NN
Mol Pharmacol; 2014 Jan; 85(1):1-10. PubMed ID: 24105977
[TBL] [Abstract][Full Text] [Related]
18. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder.
Kato T; Ishiwata M; Yamada K; Kasahara T; Kakiuchi C; Iwamoto K; Kawamura K; Ishihara H; Oka Y
Neurosci Res; 2008 Jun; 61(2):143-58. PubMed ID: 18343518
[TBL] [Abstract][Full Text] [Related]
20. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
